Literature DB >> 9226726

Anti-sexual and anxiogenic behavioral consequences of corticotropin-releasing factor overexpression are centrally mediated.

S C Heinrichs1, H Min, S Tamraz, M Carmouché, S A Boehme, W W Vale.   

Abstract

Corticotropin-releasing factor (CRF) acts as a neurotransmitter in brain to promote behavioral responses such as flight and immobility, which have adaptive value in the context of exposure to environmental stressors. CRF also suppresses behavioral repertoires such as mating, which are incompatible with such threat-related coping responses. In this study, we employed transgenic (Tg) mice which overexpress CRF in brain and exhibit a constitutive and persistent phenotype of emotionality in order to determine the consequences of long-term CRF excess on indices of reproductive success, male sexual performance and female sexual receptivity. Sexual performance of CRF Tg males was relatively intact, whereas female receptivity was masked in CRF Tg mice by active rejection of sexually experienced male counterparts. This impairment in social interaction was only partially normalized by the serotonin antagonist, methysergide, which enhanced olfactory exploration of the still non-receptive CRF Tg females. Moreover, the anxiogenic-like character of CRF Tg mice is likely to be centrally mediated, since attenuation of hypercorticosteronemia by adrenalectomy did not alter either impaired sexual receptivity or fear-like behavior in an animal model of anxiety. Thus, overexpression of CRF in the brain results in a variety of adverse consequences including diminished social interactions.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9226726     DOI: 10.1016/s0306-4530(97)00030-9

Source DB:  PubMed          Journal:  Psychoneuroendocrinology        ISSN: 0306-4530            Impact factor:   4.905


  24 in total

Review 1.  Lessons learned from gene targeting and transgenesis for adrenal physiology and disease.

Authors:  A Böttner; S R Bornstein
Journal:  Rev Endocr Metab Disord       Date:  2001-08       Impact factor: 6.514

2.  Corticotropin-releasing factor-overexpressing mice exhibit reduced neuronal activation in the arcuate nucleus and food intake in response to fasting.

Authors:  Andreas Stengel; Miriam Goebel; Mulugeta Million; Mary P Stenzel-Poore; Peter Kobelt; Hubert Mönnikes; Yvette Taché; Lixin Wang
Journal:  Endocrinology       Date:  2008-09-11       Impact factor: 4.736

Review 3.  Sex-biased stress signaling: the corticotropin-releasing factor receptor as a model.

Authors:  Rita J Valentino; Debra Bangasser; Elisabeth J Van Bockstaele
Journal:  Mol Pharmacol       Date:  2012-12-13       Impact factor: 4.436

4.  Chronic administration of the triazolobenzodiazepine alprazolam produces opposite effects on corticotropin-releasing factor and urocortin neuronal systems.

Authors:  K H Skelton; C B Nemeroff; D L Knight; M J Owens
Journal:  J Neurosci       Date:  2000-02-01       Impact factor: 6.167

Review 5.  Genetic animal models of anxiety.

Authors:  Deborah A Finn; Mark T Rutledge-Gorman; John C Crabbe
Journal:  Neurogenetics       Date:  2003-03-29       Impact factor: 2.660

6.  Enhanced pelvic responses to stressors in female CRF-overexpressing mice.

Authors:  M Million; L Wang; M P Stenzel-Poore; S C Coste; P Q Yuan; C Lamy; J Rivier; T Buffington; Y Taché
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2006-12-28       Impact factor: 3.619

7.  Assessing behavioural effects of chronic HPA axis activation using conditional CRH-overexpressing mice.

Authors:  Nina Dedic; Chadi Touma; Cristoph P Romanowski; Marcel Schieven; Claudia Kühne; Martin Ableitner; Ailing Lu; Florian Holsboer; Wolfgang Wurst; Mayumi Kimura; Jan M Deussing
Journal:  Cell Mol Neurobiol       Date:  2011-12-25       Impact factor: 5.046

8.  Altered social behavior in pituitary adenylate cyclase-activating polypeptide type I receptor-deficient mice.

Authors:  Arnaud Nicot; Timothy Otto; Philippe Brabet; Emanuel M Dicicco-Bloom
Journal:  J Neurosci       Date:  2004-10-06       Impact factor: 6.167

Review 9.  Innovative approaches for the treatment of depression: targeting the HPA axis.

Authors:  Fiona Thomson; Mark Craighead
Journal:  Neurochem Res       Date:  2007-10-25       Impact factor: 3.996

Review 10.  50 years of hurdles and hope in anxiolytic drug discovery.

Authors:  Guy Griebel; Andrew Holmes
Journal:  Nat Rev Drug Discov       Date:  2013-09       Impact factor: 84.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.